Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Sanofi (SNY)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
53.10+1.06 (+2.04%)
At close: 04:00PM EDT
53.00 -0.10 (-0.19%)
After hours: 05:47PM EDT
Advertisement
Advertisement
Show:
Annual

Income Statement

Currency in EUR. All numbers in thousands
Breakdown
ttm
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
45,389,000
45,389,000
39,175,000
37,369,000
37,631,000
Cost of Revenue
13,695,000
13,695,000
12,255,000
12,157,000
11,976,000
Gross Profit
31,694,000
31,694,000
26,920,000
25,212,000
25,655,000
Operating Expense
19,813,000
19,813,000
17,773,000
17,319,000
18,429,000
Operating Income
11,881,000
11,881,000
9,147,000
7,893,000
7,226,000
Net Non Operating Interest Income Expense
-231,000
-234,000
-328,000
-337,000
-303,000
Other Income Expense
-1,228,000
-3,379,000
-1,021,000
6,248,000
-4,101,000
Pretax Income
10,422,000
8,268,000
7,798,000
13,804,000
2,822,000
Tax Provision
2,006,000
1,503,000
1,558,000
1,813,000
139,000
Earnings from Equity Interest Net of Tax
68,000
68,000
39,000
359,000
255,000
Net Income Common Stockholders
8,371,000
6,720,000
6,223,000
12,314,000
2,806,000
Diluted NI Available to Com Stockholders
8,371,000
6,720,000
6,223,000
12,314,000
2,806,000
Basic EPS
-
3.35
2.48
4.91
1.10
Diluted EPS
-
3.33
2.48
4.88
1.09
Basic Average Shares
-
2,503,800
2,505,000
2,507,200
2,499,800
Diluted Average Shares
-
2,513,800
2,515,800
2,520,200
2,514,200
Total Operating Income as Reported
10,656,000
8,502,000
8,126,000
14,141,000
3,125,000
Total Expenses
33,508,000
33,508,000
30,028,000
29,476,000
30,405,000
Net Income from Continuing & Discontinued Operation
8,371,000
6,720,000
6,223,000
12,314,000
2,806,000
Normalized Income
9,063,406
9,148,263
7,036,008
7,546,640
6,360,840
Interest Income
241,000
206,000
40,000
53,000
141,000
Interest Expense
472,000
440,000
368,000
390,000
444,000
Net Interest Income
-231,000
-234,000
-328,000
-337,000
-303,000
EBIT
10,894,000
8,708,000
8,166,000
14,194,000
3,266,000
EBITDA
14,314,000
-
-
-
-
Reconciled Cost of Revenue
12,328,000
13,695,000
12,255,000
12,157,000
11,976,000
Reconciled Depreciation
3,420,000
2,053,000
1,580,000
1,681,000
2,146,000
Net Income from Continuing Operation Net Minority Interest
8,371,000
6,720,000
6,223,000
12,314,000
2,907,000
Total Unusual Items Excluding Goodwill
-858,000
-3,009,000
-1,016,000
6,112,000
-4,428,000
Total Unusual Items
-858,000
-3,009,000
-1,016,000
6,112,000
-4,428,000
Normalized EBITDA
15,172,000
13,770,000
10,762,000
9,763,000
9,840,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-165,594
-580,737
-202,992
1,344,640
-974,160
Advertisement
Advertisement